Overexpression of mitochondrial serine hydroxymethyltransferase (SHMT2) and glycine decarboxylase (GLDC) in GBM promotes tumor growth by inhibition of PKM2 activity and reduction of oxygen consumption [123]. The gene discussed is PKM; the disease is glioblastoma.